MSTN and type 1 diabetes mellitus: Further, myostatin KO mice exhibited no increase in liver and kidney weights, suggesting protection against the hepatomegaly (driven by hepatic lipidosis or glycogen overload) and renal hypertrophy that often afflict T1D patients [34,35,36,37].